Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Coagulation protein function V: diminution of antithrombin III function by acetaldehyde

A S Brecher1, K Hellman, C Dulin

  • 1Department of Chemistry, Bowling Green State University, Ohio 43403, USA.

Digestive Diseases and Sciences
|September 2, 1998
PubMed
Summary

Acetaldehyde (AcH) significantly reduces the anticoagulant activity of antithrombin III (ATIII). This interaction may explain lower ATIII levels in alcoholic liver disease patients.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cancer in young adulthood - classifying the intensity of treatment.

Acta oncologica (Stockholm, Sweden)·2022
Same author

Human papillomavirus, p16(INK4A), and Ki-67 in relation to clinicopathological variables and survival in primary carcinoma of the vagina.

British journal of cancer·2014
Same author

Impact of genomic stability on protein expression in endometrioid endometrial cancer.

British journal of cancer·2012
Same author

Differential expression of ANXA6, HSP27, PRDX2, NCF2, and TPM4 during uterine cervix carcinogenesis: diagnostic and prognostic value.

British journal of cancer·2010
Same author

Differential tissue-specific protein markers of vaginal carcinoma.

British journal of cancer·2009
Same author

Clinical and histopathologic factors related to prognosis in primary squamous cell carcinoma of the vagina.

International journal of gynecological cancer : official journal of the International Gynecological Cancer Society·2006

Area of Science:

  • Biochemistry
  • Hematology
  • Toxicology

Background:

  • Antithrombin III (ATIII) is a key anticoagulant protein.
  • Acetaldehyde (AcH) is a toxic metabolite associated with alcohol consumption.
  • Reduced ATIII levels are observed in alcoholic liver disease.

Purpose of the Study:

  • To investigate the effect of acetaldehyde on the anticoagulant activity of antithrombin III.
  • To determine if acetaldehyde directly modifies ATIII function.
  • To explore a potential mechanism for reduced ATIII in alcoholic liver disease.

Main Methods:

  • Plasma-free system using thrombin and fibrinogen.
  • Preincubation of ATIII with varying concentrations of AcH.
  • Assay of anticoagulant activity by measuring clotting times.

Related Experiment Videos

  • Purification using Sephadex G-25 minicolumns to remove excess AcH.

    • Main Results:

    • Acetaldehyde significantly reduced ATIII's ability to prolong clotting time.
    • Higher AcH concentrations resulted in greater loss of anticoagulant activity.
    • AcH-treated ATIII showed prolonged clotting times compared to controls.

    Conclusions:

    • Acetaldehyde forms adducts with functional groups on ATIII, altering its structure and charge.
    • This modification leads to reduced biological activity of ATIII.
    • Acetaldehyde-induced ATIII dysfunction may contribute to lower ATIII levels in alcoholic liver disease.